Advances in Nanocarriers for Anticancer Drugs Delivery

Area of Science:

• Oncology
• Nanotechnology
• Biomedical Engineering

Background:

• Cancer remains a leading cause of mortality worldwide, with treatment failures and limited options contributing to high death rates.
• Existing cancer treatments often suffer from inefficacy and lack of targeted delivery, necessitating novel therapeutic strategies.

Purpose of the Study:

• To elucidate the pivotal role of nanotechnology in advancing cancer treatment modalities.
• To emphasize the application of nanocarriers in targeted drug delivery for enhanced cancer therapy (cancer nanotherapy).

Main Methods:

• Review and synthesis of current research on nanocarriers for cancer drug delivery.
• Analysis of different types and mechanisms of action of nanocarriers.
• Exploration of recent advancements, challenges, and future prospects in cancer nanotherapy.

Main Results:

• Development of smart nanocarriers from various materials is a key innovation in improving cancer treatment efficacy.
• Nanotechnology enables more effective drug delivery systems, addressing limitations of conventional cancer therapies.

Conclusions:

• Nanotechnology, particularly through cancer nanotherapy and advanced nanocarriers, holds significant promise for overcoming current cancer treatment challenges.
• Continued research and development in nanocarrier technology are crucial for future breakthroughs in oncology.